INTRODUCTION
Canine granulocytic anaplasmosis (CGA) is a vector-borne infectious disease in dogs caused by Anaplasma phagocytophilum ( A. phagocytophilum ) , an obligatory intracellular bacterium of the family Anaplasmataceae ( Dumler et al . 2001 ) . The early cases in dogs were reported in the United States in 1982 and in Europe in 1988 ( Madewell & Gribble 1982 , Winkler et al . 1988 .
A. phagocytophilum has a worldwide distribution and is transmitted by various genera of Ixodes ticks. Ixodes ricinus is the main vector in Europe and the reported prevalence in ticks in Germany ranged between less than 1% to approximately 20% ( Baumgarten et al . 1999 , Silaghi et al . 2008 , Silaghi et al . 2012 , Stuen et al . 2013 . The seroprevalence of A. phagocytophilum in dogs in Germany varies by region and serologic test procedure but ranges from 19% to 50% ( Barutzki et al . 2006 , Jensen et al . 
MATERIALS AND METHODS
Between January 2006 and June 2012, 974 dogs presented with clinical signs suggestive of CGA as described in the literature ( e.g . lethargy, inappetence, fever, joint pain, thrombocytopenia, anaemia) ( Kohn et al . 2008 , Carrade et al . 2009 , Granick et al . 2009 , Eberts et al . 2011 , Ravnik et al . 2011 were tested for A. phagocytophilum DNA. Only dogs with a positive PCR for A. phagocytophilum were included in the study. A. phagocytophilum was tested for using real-time PCR targeting a 77 -bp fragment of the msp2-gene using the primers ApMSP2f (5'ATG-GAAGGTAGTGTTGGTTATGGTTATT-3 ' ) and ApMSP2r (5 ' -TTGGTCTTGAAGCGCTCGTA-3 ' and the TaqMan ® probe ApMSP2p: TGGTGCCAGGGTTGAGCTTGAGATTG as previously described ( Courtney et al . 2004 . Dogs were excluded if there was a co-infection or comorbidity documented that could have explained the clinical signs. Dogs were also excluded if the medical record data was incomplete.
The hospital records of these dogs were evaluated retrospectively for clinical signs, laboratory results, therapy and course of disease. Haematology was performed using EDTA blood analysed by the CELL-DYN ® 3500 (Abbott GmbH) in 2006 and thereafter with the SYSMEX ® XT-2000i (Sysmex GmbH) . A white blood cell differentiation was performed with microscopy of blood smears stained with Pappenheim. Thrombocytopenia was always verified, not only by blood smear examination but also by manual counting of the platelets using a Neubauer chamber. Microscopic detection of morulae in blood smears was documented in the hospital records of 13 dogs but it was not possible to retrospectively evaluate how many blood smears were thoroughly searched for morulae. Laboratory testing [electrolytes, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (AP), bilirubin, total protein, albumin, creatinine, urea] was performed using lithium-heparin plasma; until 2009 the samples were analysed with a RandomAccess-Analyser Kone Lab 30i ® Thermo (Fisher Scientific Inc.); thereafter a Kone Lab 60i ® Thermo was used. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) were measured from sodium citrate plasma with a Schnitger and Gross coagulometer (H. Amelung GmbH) using the following test kits: Thromborel ® S (Siemens), Pathromtin ® (Dade Behring Marburg GmbH), PTT-Solution (Roche). The direct Coombs test to detect IgG and IgM antibodies and C3 complement, and the detection of platelet-bound antibodies were performed at the Immunology Unit, University of Veterinary Medicine, Hannover, Germany ( Kohn et al . 2000 , Engelbrecht et al . 2002 .
Arthrocentesis of several joints was performed under general anaesthesia and aseptic conditions. Synovia was obtained and analysed using standard methods ( Kohn et al . 2005 . A qualitative eubacterial PCR was performed on the CSF in order to detect other potential bacterial pathogens. The target was the conserved 16S rRNA gene using forward primer 5'TCCTACGGGAGGCAGCAGT 3 ' and reverse primer 5'GGACTACCAGGGTATCTAATCCTGTT 3 ' ( Nadkarni et al . 2002 ) . The analysis was performed at the Institute for Microbiology und Epizootics, FU Berlin.
The dogs were examined for additional vector-borne pathogens, depending on clinical signs and travel history. If the dogs had not travelled abroad, they were only tested for Babesia canis , which is endemic to certain regions in Germany. If dogs displayed signs of joint pain or polyarthritis they were tested for Borrelia infection. Dogs derived from countries where Leishmania or Ehrlichia species are endemic were tested for these pathogens. A total of 53 dogs were tested for B. canis (IFAT n=17, PCR n=27, IFAT and PCR n=9), 23 for Ehrlichia canis (IFAT n=19, PCR n=2, IFAT and PCR n=2), 13 dogs for Leishmania infantum (IFAT n=11, IFAT and PCR n=2), and 15 dogs for Borrelia burgdorferi (ELISA n=15). Two dogs each with neurological signs were tested for Toxoplasma gondii and Neospora caninum (PCR). The analyses were performed at the Chair of Comparative Tropical Medicine and Parasitology, Munich, Germany, and at Laboklin, Bad Kissingen, Germany; Borrelia burgdorferi ELISA (n=15) was done at IDEXX Vet Med Labour GmbH, Ludwigsburg, Germany.
Statistical analysis was performed using SPSS 17·0. Descriptive statistical methods were used to calculate values for minimum, maximum, median, mean and standard deviation. The odds ratio and confidence interval for the comparison of the affected breeds with the clinic population were calculated using Farrington & Manning's method (confidence interval 95%). Statistical significance was set to P≤0·05.
RESULTS
Between 2006 and 2012, 974 dogs were tested for A. phagocytophilum using real-time PCR. A total of 72 dogs were PCR-positive, but nine of these dogs were excluded from the study: in six dogs it was not possible to determine whether clinical signs were due to anaplasmosis or due to concurrent diseases [intoxication (n=1), chronic disease (n=1), co-infections (n=4) with Babesia canis (n=2) and Ehrlichia canis (n=2)]; in three dogs data were insufficient. The study finally included 63 dogs with a positive PCR -result for A. phagocytophilum DNA.
Signalment
The 63 dogs included mixed breeds (n=18) and 17 different pure breed dogs. The most common breeds were golden retriever (n=14), cocker spaniel (n=7), Labrador retriever (n=3) and poodle (n=3), American pitbull, Irish terrier, giant schnauzer, Airedale terrier, and German shepherd (n=2 each). One each of the following breeds was represented: wire-haired dachshund, Siberian husky, great Dane, Newfoundland, beagle, Bernese mountain dog, American Staffordshire terrier, and shih-tzu. The golden retriever and cocker spaniel breeds were overrepresented compared to the total population of dogs presented to the clinic (odds ratio: 8·23; P<0·001). A total of 30 dogs were female (16 were castrated) and 33 were male (13 were castrated). The age of the dogs ranged from 1 to 15 years (median seven years).
History
All 63 dogs suffered from acute disease. Clinical signs before presentation were appreciated from 1 to 7 days (median 2 days); clinical signs were noticed 1 day before presentation in 28 dogs (44%). A total of seven dogs underwent previous treatment: six dogs received antibiotics (trimethoprim-sulfonamide, amoxicillin/clavulanic acid, enrofloxacin, penicillin-streptomycin); three of these dogs were additionally treated with glucocorticoids (prednisolone, depo cortisone), and two dogs with nonsteroidal anti-inflammatories or analgesic drugs (metamizole, meloxicam).
CGA was diagnosed between May and August in 51 dogs (81%); five dogs (8%) were diagnosed in April; 2 (3%) in September. One dog per month (2%) was diagnosed from October to December and in February and March ( Fig 1 ) . On two occasions dogs from the same household suffered from CGA. Table 1 . The majority of dogs (83 and 63%) had non-specific clinical signs such as lethargy and reduced activity (less active than usual but not lethargic) (n=53) and inappetence (n=40). Gastrointestinal signs were less common [diarrhoea (n=9), vomiting (n=5)]; further clinical signs were neurological (n=3) [seizures (n=1), neck pain (n=2)] and respiratory signs (n=3) [cough (n=2), tachypnea (n=1)]. None of the dogs reported to be polyuric and polydipsic received corticosteroids at the time polyuria and polydipsia were first recorded. Twenty-eight dogs (44%) had no history of foreign travel; 13 dogs (21%) had travelled outside of Germany to various European countries. The travel history was not documented in 22 of the dogs.
Physical examination
The rectal temperature at the time of presentation ranged from 38·3 to 41·2°C (median 39·7°C). Of 61 dogs, 41 (47%) had fever (>39·0°C) with temperatures between 39·1 and 41·2°C (median 40·1°C). Ten dogs (16%) were lame and five dogs had joint pain on palpation (polyarthritis was suspected). In addition to the 10 dogs with lameness, chronic musculoskeletal disorders (tendosynovitis, pain of the sacral spine, pelvic limb weakness) were diagnosed in three further dogs (lameness was not the reason for presentation). Eight dogs (13%) had haemorrhage, consist- ing of petechiae (n=2), gingival bleeding (n=1), epistaxis (n=1), pulmonary haemorrhage (n=1), fresh blood in faeces (n=1), vaginal haemorrhage (n=1) or haematoma (n=1) ( Table 1 ) . Three of these dogs had severe thrombocytopenia (12, 17 and 21 k/ μ L), two dogs had moderate thrombocytopenia (34 and 43 k/ μ L). The dog with pulmonary infiltrates had a low platelet count the day before referral to the clinic. In two dogs (haematoma after surgery and vaginal haemorrhage) the platelet counts were normal or only mildly decreased (129 and 295 k/ μ L).
Diagnostic imaging
Thoracic and abdominal radiographs were taken for 54 dogs; in five dogs only thoracic radiographs and in three only abdominal radiographs were available. Abdominal ultrasound was performed in 57 dogs. Based on radiology and sonography, splenomegaly was detected in 48 dogs (84%); the spleen was sonographically homogeneous in all cases. Sonographically homogeneous hepatomegaly was present in seven dogs in addition to splenomegaly.
Laboratory results
Results for haematology and serum biochemistry are provided in Tables 2 and 3 .
Complete blood count
Thrombocytopenia was the most common finding in 86% of the dogs (n=54). Of 54 thrombocytopenic dogs, 21 (39%) had severe thrombocytopenia with platelet counts less than 30 k/ μ L (median 13·8). Of 54 dogs, 21 (39%) had moderate thrombocytopenia with counts between 30 and 100 k/ μ L (median 60). Twelve dogs (22%) had a mild thrombocytopenia (counts 100 to 165 k/ μ L, median 133). Seven of the thrombocytopenic dogs (33%) showed haemorrhage; in two dogs bleeding was not associated with low platelet counts.
Testing for platelet-bound antibodies was performed in 36 of the 54 thrombocytopenic dogs (57%); positive results were detected in 16 (44%). Platelet counts for these 16 dogs ranged from 0 to 95·8 k/ μ L (median 16·7), 12 of 16 had severe thrombocytopenia with counts less than 30 k/ μ L (0 to 26 k/ μ L, median 14). Forty-four dogs were anaemic (70%); haematocrit was less than 0·20 L/L (median 0·16) in five dogs (11%). The direct Coombs test was positive in four of 17 tested dogs (24%) (with haematocrits of 0·12, 0·22, 0·32 and 0·46 L/L), it was negative in 13 dogs (haematocrits 0·15 to 0·35 L/L; median 0·29). Of the 44 anaemic dogs, 38 (86%) were thrombocytopenic.
Altogether, 27% of the dogs showed leucocytosis and 14% of the dogs were leucopenic.
Coagulation parameters (PT and aPTT) were measured in 29 dogs: PT was prolonged in 10 dogs (34%) (reference interval until May 1, 2010: 15 to 20s, range 13·8 to 29·0s, median 20·3; reference interval after May 1, 2010: 16·5 to 25s, range 17·5 to 28·7s, median 21·1). Prolongation in aPTT was detected in 16 dogs (55%) (reference interval until May 1, 2010: 13 to 18 s, range 11·5 to 27·2 s, median 19·3; reference interval after May 1, 2010: 10 to 13·1s, range 10·2 to 16·6s, median 12·8).
Clinical biochemistry
The most common abnormalities were increased enzymes and hyperbilirubinaemia in 47 of the dogs. Bilirubin concentration was above the reference interval (5·3 to 46·18 μ mol/L, median 8·04) in 34% of dogs; 16 of these dogs (76%) were anaemic with haematocrits between 0·12 und 0·36 L/L (median 0·30). Two . These dogs were not tested for Borrelia burgdorferi , therefore Lyme nephritis could not be ruled out completely. However, a diagnosis of borreliosis is very rare in our area.
Blood smear examination
Morulae in blood smears were detected in 13 dogs, but blood smears were not systematically examined for all dogs.
Synovial fluid analysis
Synovial fluid was taken from several joints of the five dogs with suspected polyarthritis. In one dog it could not be analysed because of blood contamination. The synovial viscosity was reduced in four dogs, and the colour was turbid yellowish or reddish. The protein content was increased (>20 to 50 g/L) in at least one joint in three dogs (range 17 to 60 g/L, median 22·5 g/L). The nucleated cell count was increased (>1000 cells/ μ L) in all joints analysed (range 2700 to 21,000/ μ L, median 11,825/ μ L) and neutrophils were predominant (50 to 90%). The synovial fluid of three dogs was tested for A. phagocytophilum using realtime PCR, two of which were positive.
CSF analysis
CSF was analysed in two of three dogs with neck pain and fever. The total protein was 105 mg/dL and 87 mg/dL (reference interval 10 to 30 mg/dL). The nucleated cell count was 647 and 233 cells/ μ L (reference value <5 cells/ μ L), there was a mixed pleocytosis with a predominance of neutrophils. Samples from both dogs tested PCR negative for T. gondii, N. caninum and for eubacterial 16S RNA (PCR).
Therapy
Seventeen dogs (27%) were treated as outpatients and 46 (73%) were hospitalised between 2 and 15 days (median 4). Fifty-five dogs (87%) received a dose of 5 mg/kg doxycycline orally every 12 hours for 7 to 56 days (median 21 days). In three dogs the therapy was discontinued after 4 to 9 days due to side effects (increase of liver enzyme activities). The doxycyline was replaced by chloramphenicol or amoxicillin/clavulanic acid. Five dogs did not receive doxycycline: three of them due to poor owner compliance and one due to increased liver enzyme values. These dogs received amoxicillin/clavulanic acid alone or in combination with enrofloxacin and imidocarb, prescribed by the general practitioner. The fifth dog died from an epileptic seizure before therapy commenced. For three dogs no information regarding therapy was present in the hospital records.
In 16 dogs (25%) with signs of immune-mediated disease [immune-mediated haemolytic anaemia (IMHA; n=5), immunemediated thrombocytopenia (ITP; n=6), polyarthritis (PA; n=3), ITP and PA (n=1), intermittent fever (n=1)] an initial dose 0·5 to 1 mg/kg prednisolone treatment for every 12 hours was initiated; in most cases (n=15) treatment was initiated before receiving the results of the PCR testing for A. phagocytophilum . Six of these dogs were positive for platelet-bound antibodies (platelet counts 12 to 85 k/ μ L, median 19); haemorrhage was appreciated in four of them [petechiae (n=2), haematochezia (n=1) and gingival bleeding (n=1)].
IMHA was suspected in five dogs (erythrocyte agglutination or spherocytosis); two of them were direct Coombs' test positive (haematocrit 0·12 L/L; 0·22 L/L). The duration of prednisolone therapy was decided based on the severity of the anaemia and/ or thrombocytopenia. Prednisolone was discontinued in one dog after 2 days. Treatment duration in the remaining 15 dogs ranged from 3 to 20 weeks (median 5) at tapering dosages. Three dogs received a dose of 5 mg/kg cyclosporine every 24 hours. Two dogs were suspected to have IMHA (positive Coombs test) one had polyarthritis and was also positive for platelet-bound antibodies.
In addition all dogs were treated symptomatically [crystalloid infusions (n=46), metamizole (n=16), ranitidine (n=19), omeprazole (n=10), buprenorphine (n=3), sucralfate (n=4), metoclopramide (n=3)]. Eight dogs (13%) received blood products due to severe anaemia or thrombocytopenia: packed red blood cells (PRBCs) (n=3), whole blood (n=3), whole blood and PRBCs (n=1) and platelet-rich plasma (n=1). 
Course of disease Of 61 dogs, 59 (97%) recovered. Two dogs were lost to followup. Two dogs died, one because of epileptic seizures (on day 3), the other dog was euthanased after 14 days because of IMHA. The follow-up period in the individual dogs was dependent on the severity of their signs and on the owner compliance (2 to 89 days after initial presentation, median 24 days).
The frequency of the rechecks depended on the abnormalities of the complete blood count results. The white blood cells (WBC) normalised within 7 to 14 days in 14 of 26 dogs (54%). WBC were increased in 11 dogs at the time of the last recheck (4 to 28 days, median 17) and remained low in one dog. The haematocrit returned to reference values within a week in 11 out of 44 dogs (25%) with mild anaemia. Haematocrit values below the reference interval (0·29 to 0·41 L/L, median 0·38) were detected in 19 dogs (43%) 1 week after diagnosis. Platelet counts normalised in 31 out of 54 dogs (57%) within 1 week but took more than 7 days to return to normal in 18 dogs (33%). Thrombocytopenia persisted (counts 50 to 124 k/ μ L, median 100) in five dogs (9%) at the last recheck after 3 to 8 days (median 5).
DISCUSSION
CGA was diagnosed in 63 of 974 dogs with clinical signs suggestive of CGA presenting between January 2006 and June 2012. In 51 dogs (81%) clinical signs were seen between the months of May and August, reflecting a seasonality of CGA dependent on increased vector activity -as reported in other studies ( Greig et al . 1996 , Egenvall et al . 1997 , Poitout et al . 2005 , Kohn et al . 2008 , Granick et al . 2009 ). However, clinical signs of CGA may also be present during the winter months when vector activity is expected to be low ( Gray et al . 2009 ), perhaps due to stress or other causes of immunosuppression from an infection acquired earlier. In one experimental study, in which three dogs were inoculated with A. phagocytophilum, DNA of the infectious agent was detected upon immunosuppression up to six months after infection ( Egenvall et al . 2000 ) . In a second study, DNA was detected in two dogs up to 105 days after inoculation. These dogs were not immunosuppressed and none of them presented with clinical signs of CGA. A. phagocytophilum PCR was negative in all of the 44 experimentally infected dogs after treatment with doxycycline ( Moroff et al . 2014 ) .
The current study included dogs of 17 different breeds as well as mixed-breed dogs. The golden retriever was the breed with the highest representation. A study in Minnesota reported that golden and Labrador retrievers were the most commonly affected breeds ( Beall et al . 2008 ) . A susceptibility of certain breeds may be due to their increased popularity or varying access of certain breeds ( e.g . working dogs) to the outdoors leading to different exposure rates to the vector ( Greig & Armstrong 2006 ) . A higher risk of tick exposure in large, long-haired dog breeds has been described, therefore a higher risk of infection in these populations has been postulated ( Beck et al . 2014 ) . The age of the affected dogs ranged from 1 to 15 years (median 7 years) in this study. Comparable findings have been reported in earlier studies which report a median age between 6 and 8 years ( Poitout et al . 2005 , Kohn et al . 2008 , Granick et al . 2009 , Eberts et al . 2011 , Ravnik et al . 2011 .
Almost all of the dogs in this study were acutely affected; only one dog had clinical signs for 7 days before presentation. This is comparable to the findings in other studies ( Egenvall et al . 1997 , Goldman et al . 1998 , Poitout et al . 2005 , Kohn et al . 2008 , Granick et al . 2009 , Eberts et al . 2011 . Only one study reported that 25% of canine patients had clinical signs for more than 7 days ( Granick et al . 2009 ).
In the current study morulae were detected in 20% of the patients, although blood smears were not systematically examined for all dogs. Because of the retrospective study design, it is unclear if the blood smear examination was not performed or if it was negative in the remaining cases. In PCR-positive dogs, morulae can often not be detected in neutrophils ( Kohn et al . 2008 ) .
Common clinical signs in all studies were lethargy in 67 to 100% and fever in 69 to 95% of the dogs ( Greig et al . 1996 , Poitout et al . 2005 , Jensen et al . 2007 , Schaarschmidt-Kiener & Müller 2007 , Kohn et al . 2008 , Granick et al . 2009 , Ravnik et al . 2011 . Another common sign in earlier studies was lameness, found in 32 to 75% of dogs ( Poitout et al . 2005 , SchaarschmidtKiener & Müller 2007 , Beall et al . 2008 , Granick et al . 2009 , Eberts et al . 2011 , Ravnik et al . 2011 ). In the current study only 16% of dogs presented with musculoskeletal problems. Synovial fluid was examined in three dogs with polyarthritis and A. phagocytophilum DNA was detected in two of these dogs; to the authors' knowledge, such results have not yet been reported in other studies. Therefore, in dogs with polyarthritis a thorough search for underlying infectious agents causing secondary immune-mediated disease is mandatory ( Kohn 2011 ) .
Neurological findings linked with A. phagocytophilum infection have been described in a few studies ( Schaarschmidt-Kiener & Müller 2007 , Schaarschmidt-Kiener et al . 2008 , Eberts et al . 2011 . CSF was not examined in any of these studies. In the present study, one dog died of epileptic seizures but a histopathological examination of the brain was not possible. Two other dogs presented with mild neurological signs and fever. Respiratory signs and other signs like polydipsia, polyuria, vomiting, diarrhoea and lymphadenopathy were uncommon in the current study, which is consistent with the existing literature. In former studies the existence of co-infections was not always excluded. This fact could explain the various symptoms and especially the sometimes increased appearance of lameness. Furthermore it is known, that several genetic variants of A. phagocytophilum appear in the dog, which might be the reason for the different manifestations of clinical findings depending on the region ).
In the current study, splenomegaly was reported in a total of 84% of the dogs. Splenomegaly due to reactive hyperplasia has been documented in experimental studies . Thrombocytopenia (86%) was the most common laboratory finding in the current study which is consistent with previous studies ( Poitout et al . 2005 , Schaarschmidt-Kiener & Müller 2007 , Beall et al . 2008 , Kohn et al . 2008 , Granick et al . 2009 , Eberts et al . 2011 , Ravnik et al . 2011 ). This may be attributed to
